A carregar...
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors
BACKGROUND: The liver is the predominant site of metastases among patients with advanced neuroendocrine tumors (NETs). Prior retrospective studies have reported high response rates in patients treated with transarterial embolization (TAE). NETs are highly vascular and are known to express vascular e...
Na minha lista:
| Publicado no: | Ann Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4559904/ https://ncbi.nlm.nih.gov/pubmed/22317769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr614 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|